2022 - Research.com Best Female Scientist Award
2012 - Rhoda and Bernard Sarnat International Prize in Mental Health, National Academy of Medicine
2011 - Member of the National Academy of Sciences
2004 - Fellow of the American Academy of Arts and Sciences
2000 - Fellow of the American Association for the Advancement of Science (AAAS)
1994 - Member of the National Academy of Medicine (NAM)
Huda Akil mainly focuses on Internal medicine, Endocrinology, Neuroscience, Receptor and Opioid receptor. Her studies examine the connections between Internal medicine and genetics, as well as such issues in Nucleus, with regards to Ventral tegmental area. Her Endocrinology research is multidisciplinary, incorporating perspectives in Mineralocorticoid receptor and In situ hybridization.
In her study, Rat brain is inextricably linked to Opioid, which falls within the broad field of Neuroscience. Her research in Receptor intersects with topics in Drug tolerance, Binding site and Cell biology. Her Opioid receptor research is multidisciplinary, incorporating elements of Molecular cloning and Opioid peptide.
Huda Akil spends much of her time researching Internal medicine, Endocrinology, Neuroscience, Receptor and Pharmacology. Internal medicine and In situ hybridization are commonly linked in her work. Her Endocrinology study integrates concerns from other disciplines, such as Neuropeptide and Dynorphin.
Central nervous system, Addiction, Nucleus accumbens and Major depressive disorder are the core of her Neuroscience study. Her Receptor study results in a more complete grasp of Biochemistry. Her study ties her expertise on -Naloxone together with the subject of Pharmacology.
Her primary areas of investigation include Endocrinology, Internal medicine, Neuroscience, Major depressive disorder and Psychiatry. Her Endocrinology research incorporates themes from Receptor and Fibroblast growth factor. In Internal medicine, Huda Akil works on issues like Novelty, which are connected to Dopaminergic.
Her work in Neuroscience addresses issues such as Anxiety, which are connected to fields such as Behavioural despair test, Offspring and Physiology. Her work investigates the relationship between Major depressive disorder and topics such as Human brain that intersect with problems in Transcriptome. In her research on the topic of Psychiatry, microRNA is strongly related with Bioinformatics.
Huda Akil mostly deals with Neuroscience, Endocrinology, Internal medicine, Major depressive disorder and Bipolar disorder. Her work in the fields of Neuroscience, such as Addiction, overlaps with other areas such as SLC1A2. Her work carried out in the field of Endocrinology brings together such families of science as Receptor and Dorsolateral prefrontal cortex.
Internal medicine is closely attributed to Candidate gene in her research. Huda Akil has researched Major depressive disorder in several fields, including Hippocampal formation, Microarray, Mood disorders and Bioinformatics. Huda Akil has included themes like Anterior cingulate cortex and Schizophrenia in her Bipolar disorder study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data.
Manhong Dai;Pinglang Wang;Andrew D Boyd;Georgi Kostov.
Nucleic Acids Research (2005)
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs
S. Hong Lee;Stephan Ripke;Stephan Ripke;Benjamin M. Neale;Benjamin M. Neale;Stephen V. Faraone.
Nature Genetics (2013)
Endogenous Opioids: Biology and Function
H Akil;S J Watson;E Young;M E Lewis.
Annual Review of Neuroscience (1984)
Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications
Alfred Mansour;Charles A. Fox;Huda Akil;Stanley J. Watson.
Trends in Neurosciences (1995)
Anatomy of CNS opioid receptors
Alfred Mansour;Henry Khachaturian;Michael E. Lewis;Huda Akil.
Trends in Neurosciences (1988)
Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801.
Keith A. Trujillo;Huda Akil.
Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4
Pamela Sklar;Pamela Sklar;Stephan Ripke;Stephan Ripke;Laura J. Scott;Ole A. Andreassen.
Nature Genetics (2011)
Pattern and time course of immediate early gene expression in rat brain following acute stress.
W.E. Cullinan;J.P. Herman;D.F. Battaglia;H. Akil.
Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain
A. Mansour;H. Khachaturian;M. E. Lewis;Huda Akil.
The Journal of Neuroscience (1987)
Antagonism of stimulation-produced analgesia by naloxone, a narcotic antagonist
Huda Akil;David J. Mayer;John C. Liebeskind.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: